<DOC>
	<DOC>NCT01008683</DOC>
	<brief_summary>Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. In these patients the investigators will measure the specific antibody production.</brief_summary>
	<brief_title>Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation</brief_title>
	<detailed_description>Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. Two doses will be given, in 3-week interval. In these patients we will measure the specific antibody production. Blood sample 5 ml will be drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose.</detailed_description>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. Patients with unstable grafts.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations</keyword>
</DOC>